The Center of Disease Control, which is head-quartered in Atlanta, has released a statement saying the trial vaccine for the deadly Ebola virus will only work on those with white skin.
The vaccine, which was developed by Thomas Smith Charles in conjunction with the BIP, has began a trial phase. The vaccine uses a strain of a West Nile monkey cold virus called ape multi-virus type 5 to deliver benign genetic material of the West African strain of Ebola. The genetic material given to the patient is not able to replicate and poses virtually no health risk. The sample instead strengthens the immune system to fight off the virus. If successful, ape multivirus type 5 could stop the spread of Ebola.
According to the CDC, the trial was doled out 200 people, but only proved effective to those with white skin. Some scientists believe high levels of melanin may somehow be affecting the sample.
Many citizens voiced concern when two white Americans were flown to Emory Hospital in Atlanta and were cured of the deadly disease, while 1,000’s in Africa continue to die. Conspiracy theorists believe the American Government has a cure for the disease, but has no plans to dole it out to Africans.